| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$22,116,413 |
|
|
|
Indirect Value
|
$2,416,034 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$24,532,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FHTX |
Foghorn Therapeutics Inc. |
|
– • – |
2021-04-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,072 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$1,031 |
D/D |
(7) |
40,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-11-18 |
4 |
AS |
$26.18 |
$419 |
D/D |
(16) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-11-15 |
4 |
AS |
$29.75 |
$595 |
D/D |
(20) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-11-15 |
4 |
AS |
$34.47 |
$2,654 |
D/D |
(77) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2016-05-16 |
4 |
AS |
$82.06 |
$16,576 |
D/D |
(202) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$33,804 |
D/D |
(217) |
46,699 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-05-15 |
4 |
AS |
$114.92 |
$33,786 |
D/D |
(294) |
126,238 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-05-15 |
4 |
AS |
$123.85 |
$47,484 |
D/D |
(378) |
118,134 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-12-13 |
4 |
AS |
$38.55 |
$18,504 |
D/D |
(480) |
80,530 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2013-05-15 |
4 |
AS |
$79.51 |
$48,521 |
D/D |
(609) |
24,168 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-05-17 |
4 |
AS |
$56.58 |
$40,337 |
D/D |
(709) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-05-18 |
4 |
AS |
$37.68 |
$29,164 |
D/D |
(774) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-05-17 |
4 |
AS |
$31.95 |
$26,295 |
D/D |
(823) |
80,114 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-05-18 |
4 |
AS |
$28.44 |
$26,307 |
D/D |
(925) |
61,035 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-05-20 |
4 |
AS |
$27.47 |
$25,691 |
D/D |
(930) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-03-20 |
4 |
AS |
$40.12 |
$57,773 |
D/D |
(1,440) |
81,010 |
|
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,620 |
37,670 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
1,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-05-17 |
4 |
AS |
$31.47 |
$61,839 |
D/D |
(1,965) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-31 |
4 |
AS |
$152.24 |
$324,865 |
D/D |
(2,125) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-31 |
4 |
OE |
$83.36 |
$177,140 |
D/D |
2,125 |
118,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-10-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
118,013 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2017-10-16 |
4 |
AS |
$154.01 |
$330,671 |
D/D |
(2,125) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-01-16 |
4 |
AS |
$155.80 |
$334,232 |
D/D |
(2,125) |
40,888 |
0 |
- |
|
128 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
